Model selection and identifiability analysis of HIV and SARS-CoV-2 co-infection model with drug therapy
From MaRDI portal
Publication:6058764
Recommendations
- Model selection and mixed-effects modeling of HIV infection dynamics
- Mathematical Modelling of HIV-HCV Co-infection Dynamics in Presence of HIV Therapy
- Identifiability of HIV/AIDs models
- Practical identifiability of HIV dynamics models
- Modeling HIV dynamics under combination therapy with inducers and antibodies
- Differential Equation Modeling of HIV Viral Fitness Experiments: Model Identification, Model Selection, and Multimodel Inference
- Modeling and stability analysis of HIV/HTLV-I co-infection
- A Mathematical Model of Combined Drug Therapy of HIV Infection
- Modelling in vivo HIV dynamics under combined antiretroviral treatment
- Modeling and analysis of HIV and hepatitis C co-infections
Cites work
- scientific article; zbMATH DE number 3568468 (Why is no real title available?)
- scientific article; zbMATH DE number 3444596 (Why is no real title available?)
- A new look at the statistical model identification
- A periodic epidemic model in a patchy environment
- Convergence results and a Poincaré-Bendixson trichotomy for asymptotically autonomous differential equations
- Determining identifiable parameter combinations using subset profiling
- Dynamics of SARS-CoV-2 infection model with two modes of transmission and immune response
- Efficacy of control measures in the control of Ebola, Liberia 2014--2015
- Ensemble samplers with affine invariance
- Estimating the dimension of a model
- Estimation of constant and time-varying dynamic parameters of HIV infection in a nonlinear differential equation model
- Further analysis of the data by Akaike's information criterion and the finite corrections
- Identifiability and estimation of multiple transmission pathways in cholera and waterborne disease
- Identifiability of nonlinear systems with application to HIV/AIDS models
- Introduction to applied Bayesian statistics and estimation for social scientists.
- Investigating the effect of pyroptosis on the slow CD4+ T cell depletion in HIV-1 infection, by dynamical analysis of its discontinuous mathematical model
- Modeling and estimation of kinetic parameters and replicative fitness of HIV-1 from flow-cytometry-based growth competition experiments
- Modeling the viral dynamics of SARS-CoV-2 infection
- Modelling and stability of HIV/AIDS epidemic model with treatment
- Monte Carlo methods in Bayesian computation
- On global identifiability for arbitrary model parametrizations
- On identifiability of nonlinear ODE models and applications in viral dynamics
- On the parameters estimation of HIV dynamic models
- Parameter identifiability of nonlinear systems: The role of initial conditions.
- Practical identifiability of HIV dynamics models
- Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission
- Statistical predictor identification
- Structural and practical identifiability analysis of outbreak models
- Structural and practical identifiability analysis of zika epidemiological models
- Structural and practical identifiability issues of immuno-epidemiological vector-host models with application to Rift Valley Fever
- The structural identifiability of the susceptible infected recovered model with seasonal forcing
- The within-host viral kinetics of SARS-CoV-2
- Threshold dynamics for compartmental epidemic models in periodic environments
- Threshold virus dynamics with impulsive antiretroviral drug effects
This page was built for publication: Model selection and identifiability analysis of HIV and SARS-CoV-2 co-infection model with drug therapy
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6058764)
